The Hindu Business Line : Actimus Bio keen to tie up with Japanese cos

Actimus Bio-sciences Private Ltd, a local company conducting studies in bio-analysis and bioequivalence for pharma companies, is keen on entering the Japanese market and having tie-ups with companies there, according to Mr Michael Fernandes, CEO.

At a news conference jointly addressed by him and visiting Japanese professor, Mr Hiroki Sawa, Mr Fernandes said that Actimus had received approval from the Drug Controller-General of India recently for conducting the studies.

Three companies - Panacea (New Delhi), Hetro Drugs (Hyderabad) and Natco Pharma (Hyderabad) - had sought out Actimus to conduct studies. "We are also having negotiations with Sandoz, Dr Reddy's Labs and several other companies," he said.

He also said that the company would set up a full-fledged lab here within a year. "So far $2.5 million has been spent on setting up the facilities here at Siripuram."

The company would spend $5 million more on expanding the facilities. Many US agencies and investors are eager to invest in it, he said.

The company would initially undertake studies in generic drugs and at a later stage may venture into clinical trials on new drugs.

"We are setting up three biotech ventures in Andhra Pradesh. Actimus Bio in Vizag will focus on bio-equivalence and bio-informatic studies. Zenitex, set up in Hyderabad, will focus on cheminformatics, natural product databases and process analytical technology. The third company, Kanetra, yet to be set up, will focus on clinical trials and data management."

Prof Sawa said that pharma companies in Japan are keen on tie-ups with Indian companies such as Actimus Bio.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Suven to present pre-clinical data at US forum

Wanted: Doormen with beard and turban

Occupation under fire

Professionals as directors vs professional directors

Posco hopes to begin construction in April 2007

M&M to set up Rs 1,000-cr greenfield facility

NTPC ties up gas from spot market

Alkem ties up with Oculus Sciences

Actimus Bio keen to tie up with Japanese cos

`Varun Shipping to raise Rs 2,500 cr in phases'

Banswara Syntex bonus issue

Parsvnath gets IMS certification

Madras Cements to double captive power plant capacity

ONGC betting on identified marginal oil reserves

SKM Egg Products bullish on exports

Kumar Birla quits Tata Steel board